Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Mol Nutr Food Res. 2014 Jul 28;58(10):2023–2035. doi: 10.1002/mnfr.201400068

Table 2.

Associationsa) between variants in genes in 1-C transfer and purine and pyrimidine metabolism pathways and risk of ovarian carcinoma stratified by total folate intake: 2,281 cases and 3,444 controls of European ancestry participants in OCAC.

Total folate Intake ≤ 484 μg/d Total folate intake > 484 μg/d
Controls Cases Controls Cases
Gene SNP AAb) AB BB AA AB BB OR 95%
CI
lower
95%
CI
upper
P
value
AA AB BB AA AB BB OR 95%
CI
lower
95%
CI
upper
P
value
P
intc)
1-C transfer
SHMT1d) rs56001517 1506 232 8 991 162 5 1.05 0.85 1.29 0.656 1475 215 6 1011 108 2 0.70 0.55 0.89 0.004 0.012
SHMT1 rs7216214 1394 335 18 907 237 15 1.08 0.91 1.28 0.396 1341 340 13 925 182 12 0.76 0.63 0.92 0.004 0.006
SHMT1 rs4925179 711 786 250 501 526 131 0.88 0.79 0.99 0.03 703 775 217 469 509 144 1.03 0.92 1.16 0.606 0.048
SHMT1 rs2273026 1409 323 15 931 213 15 1.03 0.86 1.22 0.767 1363 322 11 938 172 11 0.77 0.64 0.94 0.008 0.027
Purine metabolism
IMPD1d) rs6948333 991 653 101 624 453 77 1.09 0.96 1.23 0.171 950 637 105 638 435 46 0.91 0.80 1.03 0.139 0.039
PFAS rs11649742 1049 606 92 721 378 60 0.93 0.82 1.06 0.257 1020 592 84 624 443 55 1.14 1.00 1.30 0.045 0.029
PFAS pos8110739 1659 85 0 1122 37 0 0.64 0.43 0.96 0.03 1630 64 2 1068 51 1 1.18 0.81 1.71 0.384 0.034
Pyrimidine metabolism
CTPS rs6675122 1030 611 106 615 475 69 1.18 1.04 1.33 0.009 960 619 118 624 442 56 0.98 0.86 1.11 0.706 0.034
CTPS rs41268101 1121 521 92 677 402 61 1.16 1.02 1.32 0.022 1026 568 88 670 387 45 0.95 0.83 1.09 0.441 0.034
DPYD rs667565 671 810 266 378 573 207 1.18 1.06 1.31 0.003 614 814 268 439 508 175 0.92 0.82 1.03 0.127 0.001
DPYD rs4520446 501 879 363 318 566 274 1.09 0.98 1.21 0.135 464 824 397 331 555 234 0.90 0.81 1.00 0.057 0.016
DPYD rs7522938 752 745 216 440 540 164 1.15 1.03 1.29 0.011 712 760 208 498 469 145 0.96 0.86 1.08 0.482 0.019
DPYD rs2811182 562 887 297 413 538 208 0.96 0.86 1.07 0.43 617 784 296 360 553 209 1.12 1.00 1.25 0.041 0.042
DPYS rs1962267 550 872 325 417 555 187 0.87 0.78 0.97 0.014 586 802 309 378 535 209 1.02 0.92 1.14 0.689 0.033
DPYS rs2853160 489 889 369 303 580 276 1.08 0.97 1.20 0.158 460 839 398 317 569 236 0.93 0.83 1.03 0.169 0.036
DPYS rs17834440 1295 427 25 908 239 12 0.82 0.69 0.97 0.018 1318 359 20 853 250 19 1.11 0.94 1.31 0.223 0.008
DPYS rs2853178 859 750 138 601 475 83 0.93 0.83 1.05 0.242 889 680 128 571 448 103 1.10 0.97 1.24 0.142 0.049
DPYS rs13263121 751 782 212 530 492 136 0.93 0.84 1.04 0.227 764 751 181 480 496 145 1.13 1.01 1.27 0.034 0.02
DPYS rs1319371 1053 613 81 672 422 65 1.10 0.97 1.25 0.157 1011 592 94 683 387 52 0.90 0.79 1.02 0.106 0.03
DPYS rs35450967 1034 626 87 654 435 70 1.11 0.98 1.26 0.1 982 616 99 671 397 54 0.88 0.77 1.01 0.061 0.012
PPAT rs13135046 516 857 374 362 579 216 0.91 0.82 1.01 0.079 519 837 338 314 569 239 1.08 0.96 1.20 0.198 0.023
TYMS rs2298582 1336 393 18 914 234 11 0.86 0.73 1.02 0.09 1356 327 14 864 235 22 1.21 1.02 1.44 0.027 0.006
a)

Adjusted for age (continuous), study stratum and the first five eigenvalues from principal components analysis. SNP effect was determined using a log-additive logistic regression model.

b)

Allele counts: AA=homozygous wildtype allele carriers; AB=heterozygous allele carriers; BB=homozygous variant allele carriers.

c)

P-value for interaction.

d)

SNP is located 5′ downstream of gene; all other SNPs are located in introns; ‘pos’ SNPs are novel and identified by chromosomal position.